logo-loader
NYSE:CVM

CEL-SCI Corporation

Receive alerts
Market:
NYSE
Price
1.43 USD
Day Change
-19.21%
Market Cap:
$25.15 m
52 weeks high
6.81
52 weeks low
-

In brief

CEL-SCI Corporation, a biotechnology company, is involved in the research and development of immunotherapy products for the treatment of cancer, autoimmune and infectious diseases.

The company's core capabilities include: drug discovery, research, development and manufacturing of complex biological substances.